Business Context and Reporting Period
Company: Inmune Bio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 27, 2020
Reporting Period: Single event date (July 27, 2020)
Business Context: The registrant is an emerging growth company incorporated in Nevada, with common stock (INMB) traded on The NASDAQ Stock Market LLC. The filing reports a specific media event rather than periodic financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 8-K is a current report regarding a specific event and does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The filing focuses solely on a non-financial corporate event.
Guidance, Outlook, and Other Events
- Item 8.01 Other Events: On July 27, 2020, the Company issued a press release announcing it was featured on a Fox Business News segment.
- Exhibits: The press release dated July 27, 2020, is filed as Exhibit 99.1.
- Management Commentary: No specific financial guidance, outlook, risks, or contingencies are detailed in the body of this filing.
Investor Verification Checklist
- Verify the content of the Fox Business News segment referenced in the press release (Exhibit 99.1) to understand the context of the media coverage.
- Review the Company's most recent 10-Q or 10-K filing for actual financial performance data, as this 8-K contains none.
- Confirm the Company's status as an emerging growth company and any associated reporting exemptions.